These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26813449)

  • 1. The evaluation of hormonal and psychological parameters that affect bone mineral density in postmenopausal women.
    Seven A; Yuksel B; Kabil Kucur S; Yavuz G; Polat M; Unlu BS; Keskin N
    Eur Rev Med Pharmacol Sci; 2016; 20(1):20-5. PubMed ID: 26813449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Number of teeth and hormonal profile of postmenopausal women with osteoporosis, osteopenia and normal bone mineral density--a preliminary study].
    Stagraczyński M; Kulczyk T; Leszczyński P; Męczekalski B
    Pol Merkur Lekarski; 2015 Oct; 39(232):214-8. PubMed ID: 26608487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause.
    Yoldemir T; Erenus M; Durmusoglu F
    Gynecol Endocrinol; 2012 Nov; 28(11):884-8. PubMed ID: 22731753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lumbar bone mineral density in very long-term renal transplant recipients: impact of circulating sex hormones.
    Brandenburg VM; Ketteler M; Heussen N; Politt D; Frank RD; Westenfeld R; Ittel TH; Floege J
    Osteoporos Int; 2005 Dec; 16(12):1611-20. PubMed ID: 15999293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
    Kyvernitakis I; Albert US; Kalder M; Winarno AS; Hars O; Hadji P
    Climacteric; 2015 Feb; 18(1):63-8. PubMed ID: 24884402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.
    Lambrinoudaki I; Christodoulakos G; Aravantinos L; Antoniou A; Rizos D; Chondros C; Kountouris A; Chrysofakis G; Creatsas G
    J Bone Miner Metab; 2006; 24(1):65-71. PubMed ID: 16369901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicle-stimulating hormone and bioavailable estradiol are less important than weight and race in determining bone density in younger postmenopausal women.
    Gourlay ML; Preisser JS; Hammett-Stabler CA; Renner JB; Rubin J
    Osteoporos Int; 2011 Oct; 22(10):2699-708. PubMed ID: 21125395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation.
    Wang J; Zhang W; Yu C; Zhang X; Zhang H; Guan Q; Zhao J; Xu J
    PLoS One; 2015; 10(8):e0134986. PubMed ID: 26241313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
    Han W; Bai X; Wang N; Han L; Sun X; Chen X
    Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study.
    Ghebre MA; Hart DJ; Hakim AJ; Kato BS; Thompson V; Arden NK; Spector TD; Zhai G
    Calcif Tissue Int; 2011 Oct; 89(4):295-302. PubMed ID: 21789637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicle-stimulating hormone is associated with low bone mass in postmenopausal women.
    Mattick LJ; Bea JW; Hovey KM; Wactawski-Wende J; Cauley JA; Crandall CJ; Tian L; Ochs-Balcom HM
    Osteoporos Int; 2023 Apr; 34(4):693-701. PubMed ID: 36692543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
    Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
    Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density and sex hormone status in intellectually disabled women on progestin-induced amenorrhea.
    Arvio M; Kilpinen-Loisa P; Tiitinen A; Huovinen K; Mäkitie O
    Acta Obstet Gynecol Scand; 2009; 88(4):428-33. PubMed ID: 19330573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women.
    Haden ST; Glowacki J; Hurwitz S; Rosen C; LeBoff MS
    Calcif Tissue Int; 2000 Jun; 66(6):414-8. PubMed ID: 10821876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women.
    Malacara JM; Pérez-Luque EL; Martínez-Garza S; Sánchez-Marín FJ
    Maturitas; 2004 Oct; 49(2):163-9. PubMed ID: 15474761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity as a protective factor for postmenopausal osteoporosis.
    Albala C; Yáñez M; Devoto E; Sostin C; Zeballos L; Santos JL
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1027-32. PubMed ID: 8923160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism.
    Tauchmanovà L; Pivonello R; De Martino MC; Rusciano A; De Leo M; Ruosi C; Mainolfi C; Lombardi G; Salvatore M; Colao A
    Eur J Endocrinol; 2007 Sep; 157(3):359-66. PubMed ID: 17766720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
    Földes J; Lakatos P; Zsadányi J; Horváth C
    Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women.
    Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L
    J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.